Literature DB >> 36004540

Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved.

Claudia Main1, Xinyue Chen1, Min Zhao2, Lawrence W Chamley1, Qi Chen1.   

Abstract

It is well known that many factors, including infertility, obesity, type 2 diabetes, and family history of cancer, increase the risk of developing endometrial and ovarian cancer. However, multiparous women are known to have a lower risk of developing either ovarian or endometrial cancer than nonparous women. The lack of ovulation and shifting of sex hormonal balance, with decreased estrogen levels and increased progesterone levels during pregnancy, has traditionally been thought to be the major contributor to this decreased risk. However, in reality, the mechanisms underlying this phenomenon are relatively unknown. Increasing evidence suggests that endocrine factors are unlikely to completely explain the protective effect of pregnancies, and that multiple other nonendocrine mechanisms including fetal antigens and the newly proposed dormant cells hypothesis may also be involved. In this review, we summarize recent evidence and describe the potential underlying mechanisms that may explain how pregnancy protects against the development of ovarian and endometrial cancers in women's later life.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.

Entities:  

Keywords:  endocrinal factors; endometrial cancer; fetal antigens; ovarian cancer; pregnancy; protection

Mesh:

Substances:

Year:  2022        PMID: 36004540      PMCID: PMC9574549          DOI: 10.1210/endocr/bqac141

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   5.051


  72 in total

Review 1.  Endocrinology of human parturition.

Authors:  Silvia Vannuccini; Caterina Bocchi; Filiberto M Severi; John R Challis; Felice Petraglia
Journal:  Ann Endocrinol (Paris)       Date:  2016-05-05       Impact factor: 2.478

Review 2.  Inflammation and ovarian cancer.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  Cytokine       Date:  2012-02-19       Impact factor: 3.861

3.  Phagocytosis of Extracellular Vesicles Extruded From the Placenta by Ovarian Cancer Cells Inhibits Growth of the Cancer Cells.

Authors:  Qi Chen; Victoria Rutten; Wei-Tzu Cheng; Mancy Tong; Jia Wei; Peter Stone; Lai-Ming Ching; Lawrence W Chamley
Journal:  Int J Gynecol Cancer       Date:  2018-03       Impact factor: 3.437

Review 4.  Prevention of cancers of the breast, endometrium and ovary.

Authors:  Malcolm C Pike; Celeste Leigh Pearce; Anna H Wu
Journal:  Oncogene       Date:  2004-08-23       Impact factor: 9.867

5.  The fetal antigen hypothesis for breast cancer, revisited.

Authors:  D T Janerich
Journal:  Med Hypotheses       Date:  1994-08       Impact factor: 1.538

6.  Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer.

Authors:  E Negri; S Franceschi; A Tzonou; M Booth; C La Vecchia; F Parazzini; V Beral; P Boyle; D Trichopoulos
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

Review 7.  Type I and II endometrial cancers: have they different risk factors?

Authors:  Veronica Wendy Setiawan; Hannah P Yang; Malcolm C Pike; Susan E McCann; Herbert Yu; Yong-Bing Xiang; Alicja Wolk; Nicolas Wentzensen; Noel S Weiss; Penelope M Webb; Piet A van den Brandt; Koen van de Vijver; Pamela J Thompson; Brian L Strom; Amanda B Spurdle; Robert A Soslow; Xiao-ou Shu; Catherine Schairer; Carlotta Sacerdote; Thomas E Rohan; Kim Robien; Harvey A Risch; Fulvio Ricceri; Timothy R Rebbeck; Radhai Rastogi; Jennifer Prescott; Silvia Polidoro; Yikyung Park; Sara H Olson; Kirsten B Moysich; Anthony B Miller; Marjorie L McCullough; Rayna K Matsuno; Anthony M Magliocco; Galina Lurie; Lingeng Lu; Jolanta Lissowska; Xiaolin Liang; James V Lacey; Laurence N Kolonel; Brian E Henderson; Susan E Hankinson; Niclas Håkansson; Marc T Goodman; Mia M Gaudet; Montserrat Garcia-Closas; Christine M Friedenreich; Jo L Freudenheim; Jennifer Doherty; Immaculata De Vivo; Kerry S Courneya; Linda S Cook; Chu Chen; James R Cerhan; Hui Cai; Louise A Brinton; Leslie Bernstein; Kristin E Anderson; Hoda Anton-Culver; Leo J Schouten; Pamela L Horn-Ross
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

8.  Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.

Authors:  Nicolas Wentzensen; Elizabeth M Poole; Britton Trabert; Emily White; Alan A Arslan; Alpa V Patel; V Wendy Setiawan; Kala Visvanathan; Elisabete Weiderpass; Hans-Olov Adami; Amanda Black; Leslie Bernstein; Louise A Brinton; Julie Buring; Lesley M Butler; Saioa Chamosa; Tess V Clendenen; Laure Dossus; Renee Fortner; Susan M Gapstur; Mia M Gaudet; Inger T Gram; Patricia Hartge; Judith Hoffman-Bolton; Annika Idahl; Michael Jones; Rudolf Kaaks; Victoria Kirsh; Woon-Puay Koh; James V Lacey; I-Min Lee; Eva Lundin; Melissa A Merritt; N Charlotte Onland-Moret; Ulrike Peters; Jenny N Poynter; Sabina Rinaldi; Kim Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Leo J Schouten; Louise K Sjöholm; Sabina Sieri; Anthony Swerdlow; Anna Tjonneland; Ruth Travis; Antonia Trichopoulou; Piet A van den Brandt; Lynne Wilkens; Alicja Wolk; Hannah P Yang; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

Review 9.  Estrogen and Preeclampsia: Potential of Estrogens as Therapeutic Agents in Preeclampsia.

Authors:  Chang Shu; Shumei Han; Peng Xu; Ying Wang; Tingting Cheng; Cong Hu
Journal:  Drug Des Devel Ther       Date:  2021-06-15       Impact factor: 4.162

10.  Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study.

Authors:  Helena Schock; Anne Zeleniuch-Jacquotte; Eva Lundin; Kjell Grankvist; Hans-Åke Lakso; Annika Idahl; Matti Lehtinen; Heljä-Marja Surcel; Renée T Fortner
Journal:  BMC Pregnancy Childbirth       Date:  2016-07-04       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.